Mar 22, 2024 02:00AM
Dec 27, 2022 08:30AM
Dec 20, 2022 01:30AM
Nov 14, 2022 01:15AM
Oct 3, 2022 08:33AM
Oct 3, 2022 08:30AM
Aug 22, 2022 06:00AM RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION
Aug 12, 2022 08:33AM
Aug 12, 2022 08:30AM
Jul 28, 2022 08:33AM
Jul 28, 2022 08:33AM
Jul 28, 2022 08:30AM
Jul 8, 2022 08:30AM
Jun 21, 2022 08:30AM Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
May 6, 2022 08:30AM
Apr 12, 2022 08:30AM
Jan 27, 2022 08:30AM
Jan 12, 2022 05:54PM
Jan 12, 2022 05:48PM
Oct 7, 2021 08:33AM
Oct 7, 2021 08:30AM Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
Oct 6, 2021 08:31AM
Oct 6, 2021 08:30AM
Aug 9, 2021 08:31AM
Aug 9, 2021 08:30AM
Aug 3, 2021 05:31AM
Aug 3, 2021 01:03AM
Jul 6, 2021 09:21AM NRx Pharmaceuticals (NRXP) Announces Initiation of Emergency Use Training and Extension of Phase 2/3 Inhaled ZYESAMI Trial in the Nation of Georgia
Jul 6, 2021 09:20AM
Jun 1, 2021 06:28AM
May 25, 2021 08:33AM
May 25, 2021 08:30AM
May 25, 2021 06:50AM
May 25, 2021 06:48AM
Mar 29, 2021 01:05AM NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
Mar 29, 2021 01:05AM
Mar 22, 2021 08:30AM
Feb 23, 2021 01:11PM
Feb 9, 2021 08:13AM
Feb 9, 2021 07:30AM
Jan 25, 2021 08:41AM
Jan 25, 2021 08:35AM Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for
Jan 11, 2021 01:00AM
Dec 30, 2020 01:00AM
Dec 7, 2020 01:00AM
Nov 24, 2020 10:13AM
Nov 13, 2020 05:00AM
Nov 5, 2020 01:00AM
Oct 13, 2020 01:00AM NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critica
Sep 30, 2020 01:00AM

324,251 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All